When ambition outpaces execution
Meanwhile, Intel provides a cautionary tale of ambition outpacing execution. For many years, it was at the forefront of semiconductor manufacturing technology, producing chips using the most advanced, smallest, and highest-performance fabrication nodes, pushing new nodes on schedule while rivals lagged.
But a series of missteps over the last 20 years saw the company fall behind. Recently, it has made big declarations around regaining process leadership through its “five nodes in four years” strategy, launched in 2021, and about becoming the world’s second-largest foundry by 2030.
However, despite these bold public commitments, the company reported a net loss of $18.8bn in 2024 – its worst year ever. This collapse came after two of its chip nodes, the 10nm and 7nm, were delayed by several years.
“I think we lost the discipline of cycle time,” said Intel’s Client Computing Head Jim Johnson, who joined the company more than 30 years ago. “Cycle time requires you to commit and deliver, and we started talking ourselves into, ‘Hey, we can have longer cycle times and try and lift more or do more.’”
Intel’s vaunted comeback strategy was further stalled when its new 18A chip technology, meant to rival TSMC and Samsung, simply didn’t work. Yields were around 10%, far below the 70% needed to make money. Projects were delayed or cancelled, two factories in Europe were shelved, and tens of thousands of jobs were cut. Its AI chip, Gaudi 3, failed to dent Nvidia’s dominance. Even its flagship PC chips had to be outsourced to TSMC, a symbolic blow to a company built on making its own products.
In January 2026, the company reported that it had entered high-volume production of 18A, but no outside buyers have emerged as it struggles to win back customer trust in its ability to deliver on its promises.